| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |




*
Department of Medicine, Toronto Hospital and University of Toronto,
Toronto, Ontario, Canada
Department of Medicine, Johns Hopkins University School of Medicine,
Baltimore, Maryland
Centre for Research in Neurodegenerative Disease, University of Toronto,
Toronto, Ontario, Canada
§
Division of Nephrology, Department of Medicine, Health Sciences Center,
St. Johns, Newfoundland, Canada
Correspondence to Dr. York Pei, Toronto Hospital, 13 EN-228, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4. Phone: 416-340-4257; Fax: 416-340-0029; E-mail: ypei{at}torhosp.toronto.on.ca
Abstract. An intriguing feature of autosomal dominant polycystic kidney disease (ADPKD) is the focal and sporadic formation of renal and extrarenal cysts. Recent documentation of somatic PKD1 mutations in cystic epithelia of patients with germ-line PKD1 mutations suggests a "two-hit" model for cystogenesis in type 1 ADPKD. This study tests whether the same mechanism for cystogenesis might also occur in type 2 ADPKD. Genomic DNA was obtained from 54 kidney and liver cysts from three patients with known germ-line PKD2 mutations, using procedures that minimize contamination of cells from noncystic tissue. Using intragenic and microsatellite markers, these cyst samples were screened for loss of heterozygosity. The same samples were also screened for somatic mutations in five of the 15 exons in PKD2 by single-stranded conformational polymorphism analysis. Loss of heterozygosity was found in five cysts, and unique intragenic mutations were found in seven other cysts. In 11 of these 12 cysts, it was also determined that the somatic mutation occurred nonrandomly in the copy of PKD2 inherited from the unaffected parent. These findings support the "two-hit" model as a unified mechanism for cystogenesis in ADPKD. In this model, the requirement of a somatic mutation as the rate-limiting step for individual cyst formation has potential therapeutic implications.
This article has been cited by other articles:
![]() |
R. Peces, C. Peces, E. Coto, and R. Selgas Bilineal inheritance of type 1 autosomal dominant polycystic kidney disease (ADPKD) and recurrent fetal loss NDT Plus, October 1, 2008; 1(5): 289 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tian, R. Kolb, J.-H. Hong, J. Carroll, D. Li, J. You, R. Bronson, M. B. Yaffe, J. Zhou, and T. Benjamin TAZ Promotes PC2 Degradation through a SCF{beta}-Trcp E3 Ligase Complex Mol. Cell. Biol., September 15, 2007; 27(18): 6383 - 6395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Garcia-Gonzalez, L. F. Menezes, K. B. Piontek, J. Kaimori, D. L. Huso, T. Watnick, L. F. Onuchic, L. M. Guay-Woodford, and G. G. Germino Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway Hum. Mol. Genet., August 15, 2007; 16(16): 1940 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dicks, P. Ravani, D. Langman, W. S. Davidson, Y. Pei, and P. S. Parfrey Incident Renal Events and Risk Factors in Autosomal Dominant Polycystic Kidney Disease: A Population and Family-Based Cohort Followed for 22 Years Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 710 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Nauli, S. Rossetti, R. J. Kolb, F. J. Alenghat, M. B. Consugar, P. C. Harris, D. E. Ingber, M. Loghman-Adham, and J. Zhou Loss of Polycystin-1 in Human Cyst-Lining Epithelia Leads to Ciliary Dysfunction J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1015 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamaguchi, S. J. Hempson, G. A. Reif, A.-M. Hedge, and D. P. Wallace Calcium Restores a Normal Proliferation Phenotype in Human Polycystic Kidney Disease Epithelial Cells J. Am. Soc. Nephrol., January 1, 2006; 17(1): 178 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. L.-v. Leeuwen, J. G. Dauwerse, H. J. Baelde, W. N. Leonhard, A. van de Wal, C. J. Ward, S. Verbeek, M. C. DeRuiter, M. H. Breuning, E. de Heer, et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease Hum. Mol. Genet., December 15, 2004; 13(24): 3069 - 3077. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gao, E. Joseph, D. M. Ruden, and X. Lu Drosophila Pkd2 Is Haploid-insufficient for Mediating Optimal Smooth Muscle Contractility J. Biol. Chem., April 2, 2004; 279(14): 14225 - 14231. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Igarashi and S. Somlo Genetics and Pathogenesis of Polycystic Kidney Disease J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2384 - 2398. [Full Text] [PDF] |
||||
![]() |
G. Wu, X. Tian, S. Nishimura, G. S. Markowitz, V. D'Agati, J. Hoon Park, L. Yao, L. Li, L. Geng, H. Zhao, et al. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease Hum. Mol. Genet., August 1, 2002; 11(16): 1845 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. PERSU, O. DEVUYST, N. LANNOY, R. MATERNE, G. BROSNAHAN, P. A. GABOW, Y. PIRSON, and C. VERELLEN-DUMOULIN CF Gene and Cystic Fibrosis Transmembrane Conductance Regulator Expression in Autosomal Dominant Polycystic Kidney Disease J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2285 - 2296. [Abstract] [Full Text] |
||||
![]() |
A. Persu and O. Devuyst Transepithelial chloride secretion and cystogenesis in autosomal dominant polycystic kidney disease Nephrol. Dial. Transplant., June 1, 2000; 15(6): 747 - 750. [Full Text] [PDF] |
||||
![]() |
M. Koptides, R. Mean, K. Demetriou, A. Pierides, and C. C. Deltas Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease Hum. Mol. Genet., February 12, 2000; 9(3): 447 - 452. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673